Treatment of Coats’ disease: an analysis of pooled results

201916 citationsReviewgold Open Access

Authors

Janelle Fassbender Adeniran · University of Louisville

Sarah Madison Duff · University of Louisville

Michael Mimouni · Rambam Health Care Campus

Aparna Ramasubramanian · University of Louisville

Abstract

Vitreoretinal fibrosis and TRD increase after treatment in Coats' disease. The combination of anti-VEGF agents and cryotherapy may lead to higher risk for TRD. Presence of pre-treatment fibrosis is the highest risk factor for post-treatment worsening of vitreoretinal fibrosis and TRD.

Topics & Keywords

Ocular Oncology and Treatments Retinal and Optic Conditions Ocular Diseases and Behçet’s Syndrome

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Ophthalmology

Volume 11, Issue 4, pp. 668-674

DOI: 10.18240/ijo.2019.04.23

Field-Weighted Citation Impact: 1.51